Saba Capital Management »

Ys Biopharma shares owned by Saba Capital Management

Quarter-by-quarter ownership of Ys Biopharma (YSBPW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Ys Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ys Biopharma held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ys Biopharma by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2k 97k 0.03
2023-09-30 $4.0k 97k 0.04
2023-06-30 $5.3k 97k 0.05
2023-03-31 $15k 97k 0.16

More positions owned by Saba Capital Management

Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Adams Express Company (ADX)
ClearBridge Energy MLP Fund (EMO)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Clearbridge Mlp And Mids (CEM)
Hldgs Put Option (UAL)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Blackrock Calif Mun Income T Sh Ben Int (BFZ)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Charter Communications Inc N Cl A Put Option (CHTR)

View all positions for Saba Capital Management

Top funds holding Ys Biopharma

Millennium Management
LMR Partners
Valliance Asset Management
BFAM Partners
Highbridge Capital Management
Jane Street
Bracebridge Capital
Cowen And Company
Calamos Advisors
Whitebox Advisors
D. E. Shaw & Co
Walleye Trading Advisors
Saba Capital Management
Cantor Fitzgerald, L. P.
Deutsche Bank Aktiengesellschaft

View all funds holding Ys Biopharma